Summit Therapeutics Inc (SMMT)

Date: O: H: L: C: Vol:

Summit Therapeutics Inc Azioni (SMMT) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
	12.95%220.50	195.21	224.93	234.21	568.44
Research and Development	18.94%157.73	132.62	-	-	-
Nonoperating Income/Loss	17.14%4.80	5.79	5.75	2.42	2.73
	13.87%-215.70	-189.42	-219.17	-231.79	-565.71
Attributable To Parent	13.87%-215.70	-189.42	-219.17	-231.79	-565.71
Basic Average Shares	0.35%778.18	775.46	6.31	743.42	742.62
Diluted Average Shares	0.35%778.18	775.46	6.31	743.42	742.62
Basic Earnings Per Share	16.67%-0.28	-0.24	-0.28	-0.31	-0.76
Diluted Earnings Per Share	16.67%-0.28	-0.24	-0.28	-0.31	-0.76